Phase 2Not yet recruitingINTERVENTIONAL
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
ClinicalTrials.gov · NCT07078838 · Registry updated: 2026-09-28
- Condition / research focus
- Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2027-01. Completion: 2029-03 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Tirzepatide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States